← Back
$LVTX All transactions

LAVA Therapeutics NV

▼ SELL

$ Value

$330K

Shares

228,791

Price

$1

Filed

Sep 18

Insider

Name

Versant Venture Capital VI, L.P.

Title

CIK

0001687880

Roles

10% Owner

Transaction Details

Transaction Date

2025-09-18

Code

S

Table

Non-Derivative

Ownership

Indirect

Equity Swap

No

Shares After

532,870

Footnotes

The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $1.50 to $1.56, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (1) to this Form 4. | These shares are held by Versant Venture Capital VI, L.P. ("VVC VI"). Versant Ventures VI GP-GP, LLC ("VV VI GP") is the sole general partner of Versant Ventures VI GP, L.P. ("VV VI") and VV VI is the sole general partner of VVC VI. Each of VV VI GP and VV VI may be deemed to share voting, investment and dispositive power over the shares held by VVC VI and disclaim beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein. | These shares are held by Versant Vantage I, L.P. ("VV I"). Versant Vantage I GP-GP, LLC ("VV I GP-GP") is the sole general partner of Versant Vantage I GP, L.P. ("VV I GP") and VV I GP is the sole general partner of VV I. Each of VV I GP-GP and VV I GP may be deemed to share voting, investment and dispositive power over the shares held by VV I and disclaim beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein. | The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $1.47 to $1.52, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (4) to this Form 4. | The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $1.43 to $1.51, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (5) to this Form 4.

Filing Info

Accession No.

0001193125-25-207677

Form Type

4

Issuer CIK

0001840748

Versant Venture Capital VI, L.P.'s History

Date Ticker Type Value
2025-09-30 LENZ $2.3M
2025-09-30 LENZ $1.6M
2025-09-30 LENZ $3.9M
2025-09-30 LENZ $2.7M
2025-09-30 LENZ $8K
2025-09-30 LENZ $6K
2025-09-19 LVTX $3.3M
2025-09-19 LVTX $747K
2025-09-18 LVTX $528K
2025-09-18 LVTX $330K

Other Insiders at LVTX (90d)

No other insider activity at this issuer in the last 90 days.